# Study to Evaluate Sotagliflozin in Subjects With Varying Degrees of Renal Function

> **NCT02647918** · PHASE1 · COMPLETED · sponsor: **Lexicon Pharmaceuticals** · enrollment: 50 (actual)

## Conditions studied

- Renal Impairment
- Healthy

## Interventions

- **DRUG:** Sotagliflozin
- **DRUG:** Sotagliflozin

## Key facts

- **NCT ID:** NCT02647918
- **Lead sponsor:** Lexicon Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02647918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02647918, "Study to Evaluate Sotagliflozin in Subjects With Varying Degrees of Renal Function". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02647918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*